Complex Generics Made Simple
A deep-dive into respiratory & fermentation-based APIs
The field of complex generics is steadily gaining momentum in the biopharma world. The advantage is double-fold: to increase the value for the end-patient by addressing unmet therapeutic needs, and simultaneously enable a company’s differentiation from others.
In this new whitepaper, Complex Generics Made Simple, we deep-dive into two types of complex generics – respiratory and fermentation-based APIs.
• Why these segments are key for your portfolio
• The challenges associated with the development of respiratory and fermentation APIs
• What specialized skills and equipment are needed for development of these APIs
• How to remain competitive in 2022
Oshrat Frenkel, PhD, MBA
Director, Global R&D New Technologies, Innovation and Pre-Formulation
Boglarka Szikszai, MSc
Manager of Biotechnological R&D, Fermentation SME
Aleš Gavenda, PhD
Director Teva AMSO R&D, Czech Republic & Italy
Eiron Benmor, MBA
Assoc. Director Product Management